Doubling down on need for mRNA vaccines and mAbs, Avantor puts nearly $3B in pumps and tubing company
Acquisition-happy manufacturer Avantor has positioned itself at the front of the battle against Covid-19, and Tuesday it made another move to embed itself deeper into the ongoing pandemic response.
Pennsylvania-based Avantor acquired Masterflex from Antylia Scientific for $2.7 billion in an all-cash transaction, the company announced. The acquisition is Avantor’s 43rd overall, as it has put more than $11 billion into projects since 2011, the company said, with this transaction aiming to be completed in the fourth quarter.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.